Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aeglea BioTherapeutics In...

    NASDAQ: AGLE · Real-Time Price · USD
    12.01
    0.75 (6.66%)
    At close: Nov 27, 2023, 10:00 PM

    Aeglea BioTherapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 2.33M 18.74M
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a 2.33M 18.74M
    Operating Income
    		 -208.57M -84.78M -65.65M
    Interest Income
    		 21.31M 837K 111K
    Pretax Income
    		 -207.97M -83.95M -65.66M
    Net Income
    		 -208.02M -83.81M -65.8M
    Selling & General & Admin
    		 45.78M 28.53M 27.32M
    Research & Development
    		 162.79M 58.58M 57.07M
    Other Expenses
    		 n/a -7K -122K
    Operating Expenses
    		 208.57M 87.11M 84.39M
    Interest Expense
    		 n/a 837K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 n/a 87.11M 84.39M
    Income Tax Expense
    		 -51K -136K 141K
    Shares Outstanding (Basic)
    		 374.39M 3.37M 2.63M
    Shares Outstanding (Diluted)
    		 374.39M 3.37M 2.63M
    EPS (Basic)
    		 -0.56 -24.86 -25.02
    EPS (Diluted)
    		 -0.56 -24.86 -25.02
    EBITDA
    		 -208.57M -84.78M -65.65M
    EBIT
    		 n/a -83.11M n/a
    Depreciation & Amortization
    		 n/a 1.57M 1.58M

    Add to Watchlist